Literature DB >> 3840873

Puerperal hypertension, stroke, and seizures after suppression of lactation with bromocriptine.

M Katz, D Kroll, I Pak, A Osimoni, M Hirsch.   

Abstract

The "absolute safety" of bromocriptine as a drug of choice in suppression of lactation is questioned. Two cases of cerebrovascular events after the use of bromocriptine for lactation suppression are presented, and the available, pertinent literature is reviewed.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3840873

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN： 0029-7844            Impact factor:   7.661


  4 in total

Review 1.  Pharmacokinetic changes during pregnancy and their clinical relevance.

Authors:  R Loebstein; A Lalkin; G Koren
Journal:  Clin Pharmacokinet       Date:  1997-11       Impact factor: 6.447

Review 2.  Therapeutic applications of bromocriptine in endocrine and neurological diseases.

Authors:  K Y Ho; M O Thorner
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

3.  Bromocriptine and suppression of postpartum lactation. The incidence of adverse cardiovascular effects in women of child-bearing age.

Authors:  R M Herings; B H Stricker
Journal:  Pharm World Sci       Date:  1995-07-28

4.  Pituitary injury and persistent hypofunction resulting from a peripartum non-hemorrhagic, vaso-occlusive event.

Authors:  Anita Kuriya; David V Morris; Michael H Dahan
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.